Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.3K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypophosphatemia in the first seizure clinic: Data from a second UK center.

Epilepsia open·2026
Same author

Cellular mechanisms of entorhinal cortex spontaneous and navigation-related grid cell oscillations.

Reviews in the neurosciences·2026
Same author

Attenuated Single Neuron and Network Hyperexcitability Following MicroRNA-134 Inhibition in Mice with Drug-Resistant Temporal Lobe Epilepsy.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

Inhibitory GABAergic Neuron Loss due to Oxidative Damage During Ex Vivo Acute Brain Slice Preparation Influences Genesis and Dynamics of Epileptiform Activity.

Journal of neurochemistry·2026
Same author

Fast cortical oscillations as a potential network mechanism for language processing.

Reviews in the neurosciences·2025
Same author

Reassessing vigabatrin in infantile spasms: clinical risks, mechanistic insights, and future directions.

Pediatric research·2025
Same journal

Neurological signs of possible diagnostic value in the cognitive clinic: past, present and future.

Practical neurology·2026
Same journal

Longitudinally extensive myelitis in neurosarcoidosis.

Practical neurology·2026
Same journal

Patient with bilateral horizontal gaze palsy.

Practical neurology·2026
Same journal

Orofacial pain beyond trigeminal neuralgia.

Practical neurology·2026
Same journal

Are all antibody panels equal?

Practical neurology·2026
Same journal

Management of subdural haematoma: a practical guide.

Practical neurology·2026
See all related articles

Related Experiment Video

Updated: Feb 3, 2026

Employing Aeroponic Systems for the Clonal Propagation of Cannabis
03:41

Employing Aeroponic Systems for the Clonal Propagation of Cannabis

Published on: December 1, 2021

4.6K

Cannabis and epilepsy.

Rhys H Thomas1, Mark O Cunningham2

  • 1Institute of Neuroscience, Newcastle University, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK Rhys.Thomas@newcastle.ac.uk.

Practical Neurology
|October 20, 2018
PubMed
Summary
This summary is machine-generated.

Cannabidiol (CBD) offers a potential revolution in epilepsy treatment for those unresponsive to current therapies. Understanding the difference between medical CBD and recreational products is crucial for neurologists as legalisation looms.

Keywords:
cannabidiolcannabisdravetepilepsy

More Related Videos

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
05:46

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

6.9K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.8K

Related Experiment Videos

Last Updated: Feb 3, 2026

Employing Aeroponic Systems for the Clonal Propagation of Cannabis
03:41

Employing Aeroponic Systems for the Clonal Propagation of Cannabis

Published on: December 1, 2021

4.6K
Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
05:46

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

6.9K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.8K

Area of Science:

  • Neurology
  • Pharmacology
  • Cannabinoid Science

Background:

  • A significant portion of epilepsy patients (one-third) lack seizure control with existing treatments.
  • Public opinion and regulatory landscapes surrounding cannabis and cannabis-derived products are rapidly evolving.
  • Cannabidiol (CBD) is already licensed in the USA for specific genetic epilepsies, indicating therapeutic potential.

Purpose of the Study:

  • To inform adult neurologists about the critical distinctions between pharmaceutical-grade cannabidiol medications and artisanal CBD products.
  • To prepare neurologists for increased patient inquiries regarding cannabis-based epilepsy treatments.
  • To provide essential knowledge ahead of the anticipated UK licensing of Epidiolex in 2019.

Main Methods:

  • Review of current scientific literature on cannabidiol efficacy and safety in epilepsy.
  • Analysis of regulatory trends and public perception shifts regarding medical cannabis.
  • Comparison of evidence-based pharmaceutical CBD products versus over-the-counter artisanal preparations.

Main Results:

  • Pharmaceutical-grade CBD (like Epidiolex) has robust clinical trial evidence for specific rare genetic epilepsies.
  • Artisanal CBD products lack standardized dosing, purity, and proven efficacy for epilepsy treatment.
  • The legalisation of recreational cannabis may be influenced by the acceptance of medical CBD.

Conclusions:

  • Neurologists must differentiate between evidence-based CBD medications and unregulated CBD products.
  • Educating patients on the risks and benefits of various CBD formulations is essential.
  • The evolving legal and therapeutic landscape necessitates updated knowledge for epilepsy specialists.